Soft Tissue Sarcoma: An Insight on Biomarkers at Molecular, Metabolic and Cellular Level

by Pillozzi, Serena, Bernini, Andrea, Palchetti, Ilaria, Crociani, Olivia, Antonuzzo, Lorenzo, Campanacci, Domenico, Scoccianti, Guido
Published in Cancers (Basel) (2021)

Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives

by Fancelli, Sara, Caliman, Enrico, Mazzoni, Francesca, Brugia, Marco, Castiglione, Francesca, Voltolini, Luca, Pillozzi, Serena, Antonuzzo, Lorenzo
Published in Cancers (Basel) (2021)

Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA–PEG nanoparticles

by Menconi, Alessio, Marzo, Tiziano, Massai, Lara, Pratesi, Alessandro, Severi, Mirko, Petroni, Giulia, Antonuzzo, Lorenzo, Messori, Luigi, Pillozzi, Serena, Cirri, Damiano
Published in Biometals (2021)

hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy

by Muratori, Leonardo, Petroni, Giulia, Antonuzzo, Lorenzo, Boni, Luca, Iorio, Jessica, Lastraioli, Elena, Bartoli, Gianluca, Messerini, Luca, Di Costanzo, Francesco, Arcangeli, Annarosa
Published in Onco Targets Ther (2016)

Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

by Paderi, Agnese, Giorgione, Roberta, Giommoni, Elisa, Mela, Marinella Micol, Rossi, Virginia, Doni, Laura, Minervini, Andrea, Carini, Marco, Pillozzi, Serena, Antonuzzo, Lorenzo
Published in Cancers (Basel) (2021)

Immune Checkpoint Inhibitors in the Treatment of Renal Cancer: Current State and Future Perspective

by Lavacchi, Daniele, Pellegrini, Elisa, Palmieri, Valeria Emma, Doni, Laura, Mela, Marinella Micol, Di Maida, Fabrizio, Amedei, Amedeo, Pillozzi, Serena, Carini, Marco, Antonuzzo, Lorenzo
Published in Int J Mol Sci (2020)

KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation

by Lastraioli, Elena, Antonuzzo, Lorenzo, Fantechi, Beatrice, Di Cerbo, Luisa, Di Costanzo, Alessandro, Lavacchi, Daniele, Armenio, Miriam, Arcangeli, Annarosa, Castiglione, Francesca, Messerini, Luca, Di Costanzo, Francesco
Published in Oncol Lett (2021)

A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy

by Hasic Telalovic, Jasminka, Pillozzi, Serena, Fabbri, Rachele, Laffi, Alice, Lavacchi, Daniele, Rossi, Virginia, Dreoni, Lorenzo, Spada, Francesca, Fazio, Nicola, Amedei, Amedeo, Iadanza, Ernesto, Antonuzzo, Lorenzo
Published in Diagnostics (Basel) (2021)

Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated – NIVACOR trial (GOIRC...

by Damato, Angela, Iachetta, Francesco, Antonuzzo, Lorenzo, Nasti, Guglielmo, Bergamo, Francesca, Bordonaro, Roberto, Maiello, Evaristo, Zaniboni, Alberto, Tonini, Giuseppe, Romagnani, Alessandra, Berselli, Annalisa, Normanno, Nicola, Pinto, Carmine
Published in BMC Cancer (2020)

Practical considerations in the use of regorafenib in metastatic colorectal cancer

by Loupakis, Fotios, Antonuzzo, Lorenzo, Bachet, Jean-Baptiste, Kuan, Feng-Che, Macarulla, Teresa, Pietrantonio, Filippo, Xu, Rui-Hua, Taniguchi, Hiroya, Winder, Thomas, Yuki, Satoshi, Zeng, Shan, Bekaii-Saab, Tanios
Published in Ther Adv Med Oncol (2020)

Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib

by Inghilesi, Andrea L, Gallori, Donatella, Antonuzzo, Lorenzo, Forte, Paolo, Tomcikova, Daniela, Arena, Umberto, Colagrande, Stefano, Pradella, Silvia, Fani, Bernardo, Gianni, Elena, Boni, Luca, Laffi, Giacomo, Costanzo, Francesco Di, Marra, Fabio
Published 2014

Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study)

by Giommoni, Elisa, Maiello, Evaristo, Vaccaro, Vanja, Rondini, Ermanno, Vivaldi, Caterina, Tortora, Giampaolo, Toppo, Laura, Giordano, Guido, Latiano, Tiziana Pia, Lamperini, Cinzia, Pillozzi, Serena, Boni, Luca, Antonuzzo, Lorenzo, Di Costanzo, Francesco
Published in Curr Oncol (2021)

Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study

by Salvianti, Francesca, Gelmini, Stefania, Mancini, Irene, Pazzagli, Mario, Pillozzi, Serena, Giommoni, Elisa, Brugia, Marco, Di Costanzo, Francesco, Galardi, Francesca, De Luca, Francesca, Castiglione, Francesca, Messerini, Luca, Pinzani, Pamela, Antonuzzo, Lorenzo
Published in Br J Cancer (2021)

Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study

by Antonuzzo, Lorenzo, Giommoni, Elisa, Pastorelli, Davide, Latiano, Tiziana, Pavese, Ida, Azzarello, Domenico, Aieta, Michele, Pastina, Ilaria, Di Fabio, Francesca, Bertolini, Alessandro, Corsi, Domenico Cristiano, Mogavero, Selene, Angelini, Valentina, Pazzagli, Mario, Di Costanzo, Francesco
Published in World J Gastroenterol (2015)

ROS1 rearrangements are uncommon in biliary tract cancers

by Mazzoni, Francesca, Petreni, Paolo, Vasile, Enrico, Panebianco, Michele, Casadei-Gardini, Andrea, Negri, Francesca, Lunghi, Alice, Pillozzi, Serena, Vivaldi, Caterina, Gervasi, Erika, Frassineti, Giovanni Luca, Messerini, Luca, Jocollé, Genny, Bisagni, Alessandra, Antonuzzo, Lorenzo, Rossi, Giulio
Published in Oncol Lett (2020)

HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives

by Fanotto, Valentina, Ongaro, Elena, Rihawi, Karim, Avallone, Antonio, Silvestris, Nicola, Fornaro, Lorenzo, Vasile, Enrico, Antonuzzo, Lorenzo, Leone, Francesco, Rosati, Gerardo, Giuliani, Francesco, Bordonaro, Roberto, Scartozzi, Mario, Maglio, Giovanna De, Negri, Francesca V., Fasola, Gianpiero, Aprile, Giuseppe
Published in Oncotarget (2016)

hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer Patients()

by Iorio, Jessica, Lastraioli, Elena, Tofani, Lorenzo, Petroni, Giulia, Antonuzzo, Lorenzo, Messerini, Luca, Perrone, Giuseppe, Caputo, Damiano, Francesconi, Maria, Amato, Maria Michelina, Cadei, Moris, Arcangeli, Giuseppina, Villanacci, Vincenzo, Boni, Luca, Coppola, Roberto, Di Costanzo, Francesco, Arcangeli, Annarosa
Published in Transl Oncol (2020)

Molecular classifications of gastric cancers: Novel insights and possible future applications

by Garattini, Silvio Ken, Basile, Debora, Cattaneo, Monica, Fanotto, Valentina, Ongaro, Elena, Bonotto, Marta, Negri, Francesca V, Berenato, Rosa, Ermacora, Paola, Cardellino, Giovanni Gerardo, Giovannoni, Mariella, Pella, Nicoletta, Scartozzi, Mario, Antonuzzo, Lorenzo, Silvestris, Nicola, Fasola, Gianpiero, Aprile, Giuseppe
Published in World J Gastrointest Oncol (2017)

A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours

by FAZIO, NICOLA, BUZZONI, ROBERTO, BAUDIN, ERIC, ANTONUZZO, LORENZO, HUBNER, RICHARD A., LAHNER, HARALD, DE HERDER, WOUTER W., RADERER, MARKUS, TEULÉ, ALEXANDRE, CAPDEVILA, JAUME, LIBUTTI, STEVEN K., KULKE, MATTHEW H., SHAH, MANISHA, DEY, DEBARSHI, TURRI, SABINE, AIMONE, PAOLA, MASSACESI, CRISTIAN, VERSLYPE, CHRIS
Published in Anticancer Res (2016)

Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer

by Marmorino, Federica, Salvatore, Lisa, Barbara, Cecilia, Allegrini, Giacomo, Antonuzzo, Lorenzo, Masi, Gianluca, Loupakis, Fotios, Borelli, Beatrice, Chiara, Silvana, Banzi, Maria Chiara, Miraglio, Emanuela, Amoroso, Domenico, Dargenio, Francesco, Bonetti, Andrea, Martignetti, Angelo, Paris, Myriam, Tomcikova, Daniela, Boni, Luca, Falcone, Alfredo, Cremolini, Chiara
Published in Br J Cancer (2017)